Total Payments
$536,745
2024 Payments
$180,601
Companies
38
Transactions
821
Medicare Patients
2,892
Medicare Billing
$378,392
Payment Breakdown by Category
Other$321,605 (59.9%)
Consulting$115,765 (21.6%)
Travel$75,791 (14.1%)
Food & Beverage$23,580 (4.4%)
Gifts$3.68 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $308,405 | 115 | 57.5% |
| Consulting Fee | $115,765 | 50 | 21.6% |
| Travel and Lodging | $75,791 | 169 | 14.1% |
| Food and Beverage | $23,580 | 479 | 4.4% |
| Honoraria | $13,200 | 7 | 2.5% |
| Gift | $3.68 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $263,798 | 370 | $0 (2024) |
| Medical Device Business Services, Inc. | $87,037 | 104 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $81,116 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $69,512 | 86 | $0 (2024) |
| Neurent Medical Limited | $21,783 | 53 | $0 (2024) |
| Acclarent, Inc | $5,121 | 15 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $2,297 | 16 | $0 (2018) |
| Arrinex, Inc. | $1,789 | 2 | $0 (2017) |
| Intersect ENT, Inc. | $908.00 | 14 | $0 (2022) |
| MED-EL Corporation | $738.25 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $180,601 | 197 | Optinose US, Inc. ($90,728) |
| 2023 | $81,115 | 112 | GlaxoSmithKline, LLC. ($31,605) |
| 2022 | $87,232 | 159 | OptiNose US, Inc. ($55,330) |
| 2021 | $31,231 | 57 | Optinose US, Inc. ($12,533) |
| 2020 | $34,374 | 58 | OptiNose US, Inc. ($21,945) |
| 2019 | $66,336 | 125 | OptiNose US, Inc. ($48,995) |
| 2018 | $38,650 | 87 | Medical Device Business Services, Inc. ($28,579) |
| 2017 | $17,207 | 26 | Medical Device Business Services, Inc. ($15,012) |
All Payment Transactions
821 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $1,049.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $120.20 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/12/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | Cash or cash equivalent | $14.95 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/09/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $40.50 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 12/04/2024 | Neurent Medical Limited | NEUROMARK Device (Device), NEUROMARK Radiofrequency Console | Food and Beverage | Cash or cash equivalent | $134.12 | General |
| Category: Electrosurgical, Cutting & Coagulation & Accessories | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Integra LifeSciences Corporation | ACCLARENT AERA (Device) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: ENT | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $10,400.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $160.51 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: PAIN | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $4,992.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,080.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $416.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $416.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $128.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $53.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $53.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $979.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 743 | 958 | $274,325 | $105,699 |
| 2022 | 13 | 780 | 962 | $256,058 | $100,456 |
| 2021 | 14 | 829 | 1,017 | $275,742 | $110,561 |
| 2020 | 10 | 540 | 685 | $161,335 | $61,675 |
Total Patients
2,892
Total Services
3,622
Medicare Billing
$378,392
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 88 | 139 | $38,225 | $17,976 | 47.0% |
| 30117 | Removal or destruction of growth of nose through nose | Office | 2023 | 15 | 30 | $36,000 | $16,715 | 46.4% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2023 | 27 | 62 | $58,200 | $15,234 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 220 | $30,800 | $14,347 | 46.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $22,825 | $10,109 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 102 | $21,930 | $9,949 | 45.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 117 | 117 | $26,325 | $9,021 | 34.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 40 | 42 | $10,500 | $3,882 | 37.0% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 59 | 83 | $9,960 | $2,519 | 25.3% |
| 61782 | Computer-assisted procedure outside membrane covering brain | Facility | 2023 | 15 | 15 | $9,525 | $2,028 | 21.3% |
| 69433 | Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | Office | 2023 | 11 | 12 | $4,410 | $1,890 | 42.9% |
| G0268 | Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | Office | 2023 | 32 | 32 | $3,840 | $1,180 | 30.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 21 | $1,785 | $850.22 | 47.6% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 83 | 118 | $32,496 | $15,896 | 48.9% |
| 30117 | Removal or destruction of growth of nose through nose | Office | 2022 | 11 | 25 | $30,000 | $14,732 | 49.1% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 18 | 49 | $46,200 | $12,889 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 187 | $26,043 | $12,057 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 142 | 142 | $31,774 | $11,313 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 114 | $24,350 | $11,091 | 45.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $18,961 | $8,599 | 45.3% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 48 | 51 | $12,665 | $5,022 | 39.7% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 77 | 102 | $12,204 | $3,198 | 26.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 42 | 47 | $3,935 | $1,907 | 48.5% |
| 70486 | Ct scan of face without contrast | Office | 2022 | 15 | 15 | $7,500 | $1,476 | 19.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 18 | $6,930 | $1,356 | 19.6% |
About Dr. Jeffrey Bedrosian, MD
Dr. Jeffrey Bedrosian, MD is a Otolaryngology healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1821252974.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Bedrosian, MD has received a total of $536,745 in payments from pharmaceutical and medical device companies, with $180,601 received in 2024. These payments were reported across 821 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($308,405).
As a Medicare-enrolled provider, Bedrosian has provided services to 2,892 Medicare beneficiaries, totaling 3,622 services with total Medicare billing of $378,392. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Other Specialties Otolaryngology
- Location Portland, ME
- Active Since 07/17/2008
- Last Updated 11/20/2012
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1821252974
Products in Payments
- Xhance (Drug) $263,798
- DUPIXENT (Biological) $70,892
- NUCALA (Biological) $69,512
- NEUROMARK Device (Device) $21,783
- TruDi Navigation System (Device) $10,119
- ACCLARENT Balloon Inflation Device (Device) $4,177
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $3,479
- FASENRA (Drug) $2,297
- Clarifix (Device) $1,789
- PROPEL (Device) $825.12
- VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System (Device) $738.25
- ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) $350.92
- TruDi Nav Suction (Device) $300.00
- Acclarent Aera (Device) $266.38
- NUVENT (Device) $250.11
- ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE (Device) $206.34
- FUSION (Device) $185.33
- NURTEC ODT (Drug) $167.58
- Puraply (Medical Supply) $134.66
- STEALTHSTATION S8 PLATFORM (Device) $119.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Portland
Dr. Ryan Li, M.d, M.D
Otolaryngology — Payments: $148,543
Otolaryngology $148,543
Dr. Marcus Monroe, M.d, M.D
Otolaryngology — Payments: $15,895
Otolaryngology $15,895
Dr. Stephen Maturo, Md, MD
Otolaryngology — Payments: $14,287
Otolaryngology $14,287
Dr. Timothy Hullar, Md, MD
Otolaryngology — Payments: $13,701
Otolaryngology $13,701
Jay Gantz, M.d./Ph.d, M.D./PH.D
Otolaryngology — Payments: $13,510
Otolaryngology $13,510
Mark Wax, Md, MD
Otolaryngology — Payments: $12,644
Otolaryngology $12,644